Outpatient self-management of warfarin therapy: A pilot study

Pharmacotherapy

Volumn 19, Issue 6, 1999, Pages 787-793

  Sunderji, Rubina ^a,b   Campbell, Lara ^a   Shalansky, Karen ^a,b   Fung, Anthony ^a,b   Carter, Cedric ^a,b   Gin, Kenneth ^a,b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HOME MONITORING; HUMAN; LABORATORY TEST; MALE; MONITOR; NOMOGRAM; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; PATIENT EDUCATION; PATIENT SATISFACTION; PILOT STUDY; SELF MEDICATION;

ADMINISTRATION, ORAL; ADULT; AGED; AMBULATORY CARE; ANTICOAGULANTS; DRUG MONITORING; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; SELF ADMINISTRATION; WARFARIN;

EID: 0033038610     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.9.787.31546     Document Type: Article

References (26)

1. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H. Oral anticoagulants. Chest 1995;108 (suppl):231-46S.
2. Forfar JC. A 7-year analysis of haemorrhage in patients on long-term anticoagulation treatment. Br Heart J 1979; 42:128-32.
3. Bernardo A. Post-conference session: experience with patient self-management of oral anticoagulation. J Thromb Thrombolysis 1996;2:321-5.
4. Friedli B, Aerichide N, Grondin P, Campeau L. Thromboembolic complications of heart valve prostheses. Am Heart J 1971;81:702.
5. Ansell JE, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995;155:2185-9.
6. Bath PMW, Prasad A, Brown MM, MacGregor GA. Survey of use of anticoagulation in patients with atrial fibrillation. Br Med J 1993;307:1045.
7. McCrory DC, Matchar DB, Samsa G, Sanders LL, Prichett EL. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995;155:277-81.
8. The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. Can J Cardiol 1998;14:695-702.
9. Ansell JE, Hughes R. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J 1996;132:1095-1100.
10. Garabedian-Ruffalo S, Gray D, Sax MJ, Ruffalo RL. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985;42:304-8.
11. Wilson-Norton JL, Gibson DL. Establishing an outpatient anticoagulation clinic in a community hospital. Am J Health-Syst Pharm 1996;53:1151-7.
12. Wilt VM, Gums JG, Ahmed OI, Moore LM. Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy 1995;15:732-9.
13. Cortelazzo S, Finazzi G, Viero P, et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prostheses attending an anticoagulation clinic. Thromb Haemost 1993;43:152-4.
14. Hasenkam JM, Kimose HH, Knudsen L, et al. Self-management of oral anticoagulation therapy after heart valve replacement. Eur J Cardiothorac Surg 1997;11:935-42.
15. Ansell JE, Buttaro ML, Thomas OV, et al. Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Ann Pharmacother 1997;31:604-15.
16. Becker R, Andrew M, Ansell J, Decker D, Triplett D, Sheperd A. Multicenter trial of accurate home self-testing in oral anticoagulant patients with a novel whole blood system [abstr]. Presented at the American College of Cardiology, March 19, 1997.
17. Pell JP, McIver B, Stuart P, Malone DNS, Alcock J. Comparison of anticoagulation control among patients attending general practice and a hospital anticoagulation clinic. Br J Gen Pract 1993;43:152-4.
18. The Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomized clinical trial. Lancet 1996;348:633-8.
19. Meschengieser SS, Fondevila CG, Frontroth J, Santarelli MT, Lazzari MA. Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg 1997;113(5):910-16.
20. Turpie AGG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993;329:524-9.
21. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
22. Tattersall R, Gale E. Patient self-monitoring of blood glucose and refinements of conventional insulin treatment. Am J Med 1981;70:177-82.
23. Kumar S, Haigh JRM, Rhodes LE, et al. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost 1989;62:729-32.
24. Kaatz SS, White RH, Hill J, Mascha E, Humphries JE, Becker DM. Accuracy of laboratory and portable monitor international normalized ratio determinations: comparison with a criterion standard. Arch Intern Med 1995;155:1861-7.
25. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993;153:1441-7.
26. Foulis PR, Wallach PM, Adelman HM, et al. Performance of the Coumatrak system in a large anticoagulation clinic. Am J Clin Pathol 1995;103:98-102.